← Back to guidelines
Cardiology46 papers

Antepartum fetal asphyxia

Last edited: 4/15/2026

Overview

Antepartum fetal asphyxia refers to impaired oxygen and nutrient delivery to the fetus before birth, often indicated by abnormal fetal heart rate patterns and confirmed by metabolic markers such as umbilical cord pH levels 1.

Diagnosis

  • Key Diagnostic Criteria: Non-reassuring fetal heart rate tracings indicative of autonomic imbalance 1.
  • Recommended Tests: Umbilical cord arterial pH measurement post-birth to confirm asphyxia 1.
  • Grading: Low umbilical cord pH (<7.2) and elevated base deficit are indicative of fetal asphyxia 1.
  • Management

  • First-Line Treatments: Immediate delivery if fetal distress is confirmed to prevent further hypoxia 1.
  • Adjunctive Treatments: No specific pharmacological interventions mentioned for antepartum fetal asphyxia in the provided abstracts 1.
  • Special Populations

  • Pregnancy: No specific considerations unique to different stages of pregnancy are detailed in the abstracts 1.
  • Comorbidities: No specific management adjustments for comorbidities related to fetal asphyxia are addressed 1.
  • Key Recommendations

  • Monitor fetal heart rate patterns closely during labor for signs of autonomic imbalance indicative of potential asphyxia (Evidence: Moderate 1).
  • Confirm suspected antepartum fetal asphyxia with umbilical cord arterial pH measurement post-birth (Evidence: Moderate 1).
  • Initiate prompt delivery if fetal distress is confirmed to mitigate risks associated with ongoing asphyxia (Evidence: Expert opinion 1).
  • References

    1 Butruille L, De Jonckheere J, Flocteil M, Garabedian C, Houfflin-Debarge V, Storme L et al.. Parasympathetic tone variations according to umbilical cord pH at birth: a computerized fetal heart rate variability analysis. Journal of clinical monitoring and computing 2017. link

    Original source

    1. [1]
      Parasympathetic tone variations according to umbilical cord pH at birth: a computerized fetal heart rate variability analysis.Butruille L, De Jonckheere J, Flocteil M, Garabedian C, Houfflin-Debarge V, Storme L et al. Journal of clinical monitoring and computing (2017)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG